VAERS reports by lot

GSK Varicella/Shingles lot 34L52: VAERS reports

46 VAERS reports list lot 34L52 as a GSK Varicella/Shingles vaccine, received between 2022-04-19 and 2024-05-16. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
46
Reports
0%
Marked serious
0
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1732%
General / Systemic (non-local)713%
Neurological611%
Musculoskeletal611%
Allergic / Anaphylactic48%
Gastrointestinal48%
Psychiatric / Neuropsychiatric48%
Cardiac / Cardiovascular24%
Dermatological (non-injection-site)24%
Thrombotic / Hematological12%

Where reports came from

U.S. state of the reporter, where given (top 12).

District of Columbia18
Virginia3
Ohio2
Michigan2
New York2
Florida2
Massachusetts1
Illinois1
Pennsylvania1
New Jersey1
Indiana1
California1

Reports by month received

2022-042
2022-055
2022-066
2022-071
2022-081
2022-101
2023-031
2023-072
2023-1210
2024-015
2024-026
2024-032
2024-054

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.